|
Roher, Alex E; Esh, Chera L; Kokjohn, Tyler A et al. (2009) Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement 5:18-29
|
|
Beach, T G; Potter, P E; Kuo, Y M et al. (2000) Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition. Neurosci Lett 283:12-Sep
|
|
Beach, T G; Kuo, Y M; Spiegel, K et al. (2000) The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J Neuropathol Exp Neurol 59:308-13
|
|
Roher, A E; Baudry, J; Chaney, M O et al. (2000) Oligomerizaiton and fibril asssembly of the amyloid-beta protein. Biochim Biophys Acta 1502:31-43
|
|
Lue, L F; Kuo, Y M; Roher, A E et al. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155:853-62
|
|
Kuo, Y M; Emmerling, M R; Lampert, H C et al. (1999) High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 257:787-91
|
|
Yan, S D; Shi, Y; Zhu, A et al. (1999) Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity. J Biol Chem 274:2145-56
|
|
Roher, A E; Kuo, Y M; Kokjohn, K M et al. (1999) Amyloid and lipids in the pathology of Alzheimer disease. Amyloid 6:136-45
|
|
Chaney, M O; Webster, S D; Kuo, Y M et al. (1998) Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease. Protein Eng 11:761-7
|
|
Kuo, Y M; Emmerling, M R; Bisgaier, C L et al. (1998) Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun 252:711-5
|
Showing the most recent 10 out of 15 publications
